    Barry Flannelly | Abraxis Oncology | ZoomInfo.com










 





Barry P Flannelly - Los Angeles, CA | Intelius



























Sign In



We found Barry P Flannelly in Los Angeles, CA


Barry P Flannelly

                                                                        Intelius found that Barry P Flannelly  from Los Angeles, CA.  We have connected them to
                8 addresses,
                6 phones,
                and 0 relatives or associates.
         






Get Report Now

Barry Has Lived In

Los Angeles, CA
Wilmington, DE
Schaumburg, IL







Barry P Flannelly



Professional Status
Director-communications at Onyx Pharmaceuticals , Inc.



Get Report Now










Want to know more about Barry? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Barry, or use our people search engine to find others.
Get Background Check on Barry P Flannelly
Get a Criminal Check on Barry P Flannelly
Get a Public Record Report on Barry P Flannelly
Get a People Search Report on Barry P Flannelly


Barry P Flannelly's Contact Information
Known Cities Lived In
Find out where Barry P Flannelly has lived as well as Barry P Flannelly's phone numbers and email addresses.




Barry P Flannelly Has Lived in 3 States
California Address for Barry P Flannelly


11601 W******* B*** 

Los Angeles, CA


Has Lived In

Los Angeles, CA
Wilmington, DE


Get Full Address Report










Phone Numbers Associated with Barry P Flannelly

(310) ***-**** - Los Angeles, CA 
(310) ***-**** - Los Angeles, CA 
(415) ***-**** - San Francisco, CA 


Get Full Phone Report



Email Addresses Associated with Barry P Flannelly

b********y@***.com
m******3@***.com
b*************y@***.com


Get Email Report




Barry P Flannelly's Education Information
Known Schools Attended
Learn about Barry P Flannelly's academic history.  Find out which schools Barry P Flannelly attended, the dates attended as well as the degrees Barry P Flannelly received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Barry P Flannelly Has Attended 6 Schools
Massachusetts College of Pharmacy and Health Sciences Barry P Flannelly has a Bs, Pharmacy in Pharmacy               
Massachusetts College of Pharmacy and Health Sciences                              Barry P Flannelly has a Bs in Pharmacy               
University of Baltimore                              Barry P Flannelly has a MBA, Business Administration in Business Administration               
University of Baltimore                              Barry P Flannelly has a MBA in Business Administration               
University of Maryland College Park                              Barry P Flannelly has a Pharm.d., Pharmacy in Pharmacy               
University of Maryland College Park                              Barry P Flannelly has a Pharm.d. in Pharmacy               


Barry P Flannelly's Professional Information
Information regarding Barry P Flannelly's professional history.  Find out previous places Barry P Flannelly has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Barry P Flannelly Has Worked at 19 Places
Company: Onyx Pharmaceuticals , Inc.
               Title: Director-communications
Company: Onyx Pharmaceuticals , Inc.
               Title: Manager
Barry P Flannelly's Experience
Title: Director-communications
               Company: Onyx Pharmaceuticals , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 5,000 to less than 25,000
Title: Manager
               Company: Onyx Pharmaceuticals , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 5,000 to less than 25,000
Additional Professional Information on Barry P Flannelly

 See Barry P Flannelly's LinkedIn Profile



Barry P Flannelly's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Barry P Flannelly


Barry P Flannelly's known Social Networks And Potential Email Matches

Find all of Barry P Flannelly's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Barry Flannelly
Username Matches

                  BarryFlannelly
                  FlannellyBarry
                  Barry.Flannelly
                  Flannelly.Barry
                  Barry_Flannelly
                  Flannelly_Barry
                  Barry-Flannelly
                  Flannelly-Barry
                  BFlannelly
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
B Flannelly







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














INCY Barry P. Flannelly Insider Trades for Incyte Corp.


































Bulletin






Investor Alert







New York Markets After Hours



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Incyte Corp.

                  NASDAQ: INCY
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Incyte Corp.



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:11 p.m.


INCY

/quotes/zigman/55297/composite


$
134.94




Change

-0.80
-0.59%

Volume
Volume 25,424
Quotes are delayed by 20 min








/quotes/zigman/55297/composite
Today's close

$
			132.72
		


$
				135.74
			
Change

+3.02
+2.28%





Day low
Day high
$132.18
$136.81










52 week low
52 week high

            $75.52
        

            $153.15
        


















Insider Activity


Individual




Barry P. Flannelly



Dr. Barry P. Flannelly is Executive Vice President & General Manager at Incyte Corp.
He received his undergraduate degree from the Massachusetts College of Pharmacy & Health Science, an MBA from the University of Baltimore, and a doctorate degree from the University of Maryland School of Pharmacy.



Transactions


Date
Shares
Transaction
Value





07/05/2017
3,517


 
Award at $0 per share.


0


05/01/2017
4,493


 
Disposition at $124.75 per share.


560,502


05/01/2017
803


 
Disposition at $124.61 per share.


100,062


05/01/2017
2,064


 
Derivative/Non-derivative trans. at $48.44 per share.


99,980


02/24/2017
2,473


 
Derivative/Non-derivative trans. at $121.95 per share.


301,583


02/14/2017
6,966


 
Award at $0 per share.


0


10/07/2016
24,204


 
Disposition at $97 per share.


2,347,788


10/07/2016
21,796


 
Derivative/Non-derivative trans. at $48.44 per share.


1,055,798


10/07/2016
2,408


 
Derivative/Non-derivative trans. at $48.44 per share.


116,643


07/15/2016
5,555


 
Award at $0 per share.


0


01/07/2016
2,610


 
Award at $0 per share.


0


01/08/2015
3,022


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Hervé  Hoppenot 
Chairman, President & Chief Executive Officer




Mr. David W. Gryska 
Chief Financial Officer & Executive Vice President




Mr. Michael  Morrissey 
Senior VP & Head-Global Technical Operations




Dr. Steven H. Stein 
Chief Medical Officer & Executive Vice President




Dr. Reid M. Huber 
Chief Scientific Officer & Executive VP




Dr. Vijay  Iyengar 
EVP-Global Strategy & Corporate Development




Mr. Paul  Trower 
Vice President-Finance




Dr. Phillip  Liu 
Associate Director-Applied Technology




Dr. Holly  Koblish 
Associate Director




Dr. Barry P. Flannelly 
Executive Vice President & General Manager




Dr. Keith  Mikkelson 
Executive Director-Business Development




Dr. Kim  Solomon 
Vice President-Project Management




Dr. Robert  Newton 
Vice President-Drug Discovery Biology




Dr. Wenqing  Yao 
Executive Vice President-Discovery Medicinal




Dr. Paul A. Friedman 
Director




Ms. Catalina  Loveman 
Head-Media Relations




Ms. Lauren  Kwiecinski 
Director-Investor Relations




Dr. Michael Charles A.  Booth 
Vice President-Investor Relations




Ms. Paula J. Swain 
Executive Vice President-Human Resources




Mr. Eric H. Siegel 
Secretary, Executive VP & General Counsel




Mr. Julian Charles Baker 
Lead Independent Director




Mr. Paul J. Clancy 
Independent Director




Mr. Jean-Jacques  Bienaimé 
Independent Director




Dr. Wendy L. Dixon 
Independent Director




Mr. Paul Alan Brooke 
Independent Director
















Log In




4:29 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
4:29pJared Kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere
4:28pHere’s how much you should spend on a yoga mat 
4:26p5 weird things I found out about America in my first 24 hours 
4:26pWeekend Sip: Is this the world’s first distilled non-alcoholic spirit?
4:22pGoodyear stock stumbles 11% after quarter ‘played out differently than we expected’
4:21pTime for GOP to face reality: Everybody is going to have health insurance
4:19pBREAKINGDow industrials just 170 points shy of 22,000 milestone
4:17pWhy tax cuts for the rich solve nothing
4:10pCigarette maker stocks plunge on FDA announcement, but health experts are skeptical
4:08p‘Game of Thrones’: The four biggest takeaways from 'Stormborn’
4:08pAmazon’s stock drop after results is the smallest in seven years
4:07pRussell’s ‘line in the sand’ against Snap could give investors more control
4:07p‘Game of Thrones’ science: Let’s take a closer look at that greyscale
4:06pDow Jones Industrial Average advances more than 1% this week 
4:06pComcast is trying to win over millennials with new streaming service
4:06pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
4:05pStocks end muddled for the week on mixed batch of second-quarter earnings
4:05pBREAKINGDow ends at record; S&P 500, Nasdaq see weekly fall
4:05p‘Atomic Blonde’ shows — again — kick-ass roles for women are good for Hollywood
4:03p‘Game of Thrones’: New photos of episode 3 tease meeting of fire and ice
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











Leadership | Incyte.com








































For Patients
For HCPs
For Media

Contact Us













Search


















Who We Are

Our Commitment
Our Leadership



What We Do

Discover
Develop
Deliver
Collaborate
Incyte Involved



Join Us

Our Culture
Your Career



For Investors

Investor Overview
Press Releases

Events & PresentationsEvents &  Presentations

Financial InformationFinancial Information
Stock Information





















Toggle navigation









 





Search






Who We Are


Our Commitment
Our Leadership



What We Do


Discover
Develop
Deliver
Collaborate
Incyte Involved



Join Us


Our Culture
Your Career



For Investors 


Investor Overview
Press Releases
Events & Presentations
Financial Information
Stock Information








For Patients
For HCPs
For Media

Contact Us





















Who We Are
Our Leadership









Our Leadership

                    Incyte Corporation's executive management team includes accomplished leaders with deep and broad industry experience. Led by Chairman, President, and Chief Executive Officer Hervé Hoppenot, Incyte currently employs more than 900 people across the United States and Europe.
                











Hervé Hoppenot
Chairman, President, and Chief Executive Officer
Hervé Hoppenot joined Incyte in 2014 as President and Chief Executive Officer, and was appointed Chairman of the Board of Directors in 2015. Prior to joining Incyte, Mr Hoppenot was the President of Novartis Oncology, where he was responsible for translational medicine, development, approval, and commercialization, which included $11 billion in global sales, the largest oncology pipeline in the industry, and 8000 employees in 50 countries. Mr Hoppenot joined Novartis in 2003, and, in addition to his role as President, served as Chief Commercial Officer, Head of Global Product Strategy & Scientific Development, and Senior Vice President, Head of Global Marketing. He started his career in 1983 with Rhone Poulenc, later known as Aventis, where he served in several senior roles of increasing responsibility, including Vice President of Oncology and Head of the US Oncology business unit. Mr Hoppenot holds a diploma from ESSEC Business School.







Jonathan E. Dickinson
Senior Vice President, General Manager, Europe
Jonathan Dickinson joined Incyte as Senior Vice President and General Manager, Europe in June 2016. Mr. Dickinson joined Incyte from ARIAD Pharmaceuticals (Europe) Sàrl where he most recently held the position of Senior Vice President and General Manager, Europe. Prior to ARIAD, Mr. Dickinson served as European oncology brand lead at Bristol-Myers Squibb and before that, he held several key leadership positions, including lifecycle leader, during his 13-year tenure at Hoffmann-La Roche. At Roche, he had assignments both in the United States and Switzerland that included leadership roles for Roche’s three leading oncology medicines. Mr. Dickinson began his career at Novartis, where he held commercial roles in its oncology and endocrinology businesses, including medical sales, product manager and business director in the United Kingdom. Mr. Dickinson received his Bachelor of Science degree in Genetics and his MBA degree from the University of Nottingham.







Barry P.  Flannelly, PharmD, MBA
Executive Vice President, General Manager US
Barry Flannelly joined Incyte as Executive Vice President, Business Development and Strategic Planning, in August 2014 and was appointed General Manager US in June 2015. Dr Flannelly has been working in oncology since 1987, and began his career in the pharmaceutical and biotech industry at Rhone-Poulenc Rorer, which later became Sanofi-Aventis. He has since had roles of increasing responsibility at Novartis Pharmaceuticals Corporation, Abraxis Oncology, Onyx Pharmaceuticals Inc., and Nektar Therapeutics. During his career, he has held positions in medical affairs, strategic planning, commercial operations, including head of sales and head of marketing, and business development. He earned his Doctor of Pharmacy from the University of Maryland School of Pharmacy, his Master in Business Administration from the University of Baltimore, and his Bachelor of Science in Pharmacy from Massachusetts College of Pharmacy.







David W. Gryska
Executive Vice President, Chief Financial Officer

                David Gryska joined Incyte as Executive Vice President and Chief Financial Officer in October 2014 and brings more than 30 years of finance experience to the Company. Before joining Incyte, Mr Gryska served as Chief Financial Officer at both Celgene Corporation and Scios, Inc. From 1982 to 1993, Mr Gryska worked at Ernst & Young, LLP. Mr Grsyka is a CPA and earned his MBA from Golden Gate University.

            







Reid M. Huber, PhD
Executive Vice President, Chief Scientific Officer
Reid M. Huber joined Incyte as a member of the founding scientific team in January 2002 and has more than 17 years' experience in the pharmaceutical/biotech industry. For the past 13 years, Dr Huber has held roles of increasing responsibility across multiple therapeutic areas in both Drug Discovery and Clinical Development at Incyte. In 2011, Dr Huber assumed responsibility for the company's research activities as Senior Vice President, Discovery Biology. Before joining Incyte, Dr Huber held scientific research positions at DuPont  and Bristol-Myers Squibb Company from 1998 to 2002. Dr Huber received his PhD in molecular genetics from the Washington University Medical School and held predoctoral and postdoctoral fellowships at the National Institutes of Health.







Vijay Iyengar, MD
Executive Vice President, Global Strategy and Corporate Development
Vijay Iyengar joined Incyte in May 2016 as Executive Vice President, Global Strategy and Corporate Development leading the company’s Global Product Strategy, Business Development and Licensing and Alliance Management teams. Dr. Iyengar has more than 13 years of pharmaceutical industry experience, most recently serving as the President of Genoptix Corporation, a Novartis Company. At Genoptix, he led a 650-person organization focused on delivering CAP/CLIA certified oncology diagnostic testing as well as providing clinical trial assay development and execution services. Previous to that, Dr. Iyengar held leadership roles in both U.S. and Global commercial functions at Novartis—he was Vice President and Rare Diseases Franchise Head at Novartis Oncology and Vice President and Oncology General Manager of Novartis Greece. Before joining Novartis in 2003, Dr. Iyengar was an Engagement Manager at McKinsey & Company where he served pharmaceutical and medical device clients as part of their healthcare practice.  Dr. Iyengar received his Bachelor of Science degree in Biology from Stanford University and earned his MD from Harvard Medical School.







Michael Morrissey
Corporate Senior Vice President, Head of Global Technical Operations
Michael Morrissey joined Incyte in January 2016 as Corporate Senior Vice President and Head of Global Technical Operations. He has more than 30 years of global pharmaceutical industry experience through his prior positions in Research and Development, Quality Assurance, and Manufacturing. Most recently, Mr Morrissey served as Corporate Vice President, Head of International Technical Operations at Celgene International, where he built the company’s internal production and distribution capabilities and launched Celgene’s drugs worldwide. Prior to Celgene, he worked for Roche for 15 years in various positions. Mr Morrissey holds a diploma in Physics and Applied Mathematics from the University of London, United Kingdom.







Eric H. Siegel, JD, MBA
Executive Vice President, General Counsel
Eric Siegel joined Incyte as the Chief Compliance Officer in October 2010 and became Executive Vice President and General Counsel in August 2011. Before joining Incyte, from April 2009 to October 2010, he was Chief Compliance Officer at EMD Serono, a privately held biotechnology company. From 2007 to 2009, he served as General Counsel for Solstice Neurosciences, also a privately held biotechnology company. He was Vice President, Deputy General Counsel and Chief Compliance Officer at Cephalon, Inc. from 2004 to 2007. Mr Siegel holds a BA from Franklin and Marshall College, his MBA from Temple University and his JD from the University of Pennsylvania.







Steven H. Stein, MD
Executive Vice President, Chief Medical Officer
Steven Stein joined Incyte as Senior Vice President and Chief Medical Officer in March 2015, and has over 10 years of experience in clinical development and regulatory interactions. Dr Stein joined Incyte from Novartis Pharmaceuticals Corporation, where he most recently served as Senior Vice President, US Clinical Development & Medical Affairs at Novartis Oncology US Dr Stein previously worked at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and also as Head of Medicines Development for Hematology and Supportive Care. Dr Stein earned his MD from the University of Witwatersrand in Johannesburg, South Africa.







Paula J. Swain
Executive Vice President, Human Resources
Paula Swain joined Incyte in January 2002 and serves as Executive Vice President of Human Resources. Before joining the company, Ms Swain spent nearly 10 years with DuPont (acquired by Bristol-Myers Squibb Company in 2001) where she served as Vice President and Senior Vice President of Human Resources. She has also held human resource planning and employee relations positions with Chase Manhattan Bank, Marine Midland Bank and Delaware Trust Company. Ms Swain received her BA in psychology from Rockhurst College and graduated from the strategic human resources planning program at Harvard Business School.







Wenqing Yao, PhD
Executive Vice President, Discovery Chemistry
Wenqing Yao joined Incyte in February 2002 as Director, Chemistry. Dr Yao has over 20 years of experience in medicinal chemistry. For the past nine years, Dr Yao has held roles of increasing responsibility at Incyte, most recently as Senior Vice President, Discovery Chemistry. Prior to joining Incyte, Dr Yao held scientific research positions with DuPont and Bristol-Myers Squibb Company from 1996 to 2002. Dr Yao received his BS in chemistry from Xuzhou Normal University, his MS in organic chemistry from NanKai University and his PhD in organic/medicinal chemistry from the University of Pennsylvania.





Board Of Directors





Hervé Hoppenot
Chairman, President and Chief Executive Officer, Incyte Corporation
Julian C. Baker
Managing Partner, Baker Brothers Investments
Jean-Jacques Bienaimé
Chief Executive Officer, BioMarin Pharmaceutical, Inc.
Paul A. Brooke
Founder and Former Managing Director, venBio
Paul J. Clancy
Chief Financial Officer, Alexion Pharmaceuticals, Inc.
Wendy Dixon, PhD
Former Chief Marketing Officer and President, Global Marketing, Bristol-Myers Squibb Company
Paul A. Friedman, MD
Former President and Chief Executive Officer, Incyte Corporation
















You are now leaving Incyte.com  Do you want to continue?







YES
Take Me There


 


NO
I Changed My Mind
















News on Barry P. Flannelly


























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology















                                Person                            


                                    Barry P. Flannelly                                    ▼





                                Topic                            


                                    All Topics                                    ▼








Organizations

                                Find news about organizations
                            





Alumni

                                Find news on alumni of any org
                            





Industries

                                Find news on a particular market
                            





Your Contacts

                                Find news on your contacts
                            








Sign up for free daily alerts on this feed:











By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


















Follow




                            Change Feed
                        


Barry P. Flannelly











Insider Transactions


                                May 8, 2017                                 • 
                                Philadelphia Inquirer                            


                                  ... at $124.26 on Apr. 28, and now directly holds 3,677 shares. Barry P. Flannelly, officer, sold 5,296 shares at $124.61 to $124.75 on May 1, ...
                                









Barry P. Flannelly sold $1.18M worth of shares in Incyte Corp. in October 2016


                                November 8, 2016                                 • 
                                RelSci Data Update                            










Insider Transactions


                                October 17, 2016                                 • 
                                Philadelphia Inquirer                            


                                  ... on Oct. 11, and now directly holds 4,717,626 shares. Incyte Corp. Barry P. Flannelly, officer, sold 24,204 shares at $97.00 on Oct. 7, and now ...
                                









Incyte announces organizational changes


                                July 1, 2015                                 • 
                                Marketline Newswire                            


                                  ... to make a major difference for cancer patients in the years ahead." Barry Flannelly, Pharm. D., has been appointed to the newly created position of ...
                                









Incyte Announces Organizational and Management Changes to Drive Future Global Expansion


                                June 19, 2015                                 • 
                                Business Wire                            


                                  ... to make a major difference for cancer patients in the years ahead." Barry Flannelly, Pharm. D., has been appointed to the newly created position of ...
                                







Related News Feeds






Incyte Corp.







Pharmaceuticals







Board and Executive Moves in Pharmaceuticals







Alumni of University of Maryland - School of Pharmacy

























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink



 






Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!


Start My Free Trial  ➤










 Industry:




 Select a Topic:



 Keyword:



Go  ➤









 Find an Organization:






 Select a Topic:




 Keyword:




Go  ➤









 Find a Person:






 Select a Topic:




 Keyword:




Go  ➤









 Name of a School:







 Or Name of an Organization:









 Select a Topic:




 Keyword:




Go  ➤








Thank you. You are now subscribed.Please wait for the page to refresh...










You are now subscribed to this feed.










You have unsubscribed to this feed.










Thank you. You can now subscribe to more RelSci news feeds.










 To subscribe to more than one feed, please enter a password.




 Please confirm your password



Go  ➤








You've found a premium RelSci Pro feature!



Follow News On Your Contacts

Upgrade to RelSci Pro now to easily sync your contacts and stay in the know on the news about the people important to you.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now








You've found a premium RelSci Pro feature!



Search News On Keywords

Curate your news even further with the ability to filter feeds based on specific keywords mentioned in the articles.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now













Industries

                        Find news on a particular market
                    





People

                        Find news about people
                    





Organizations

                        Find news about organizations
                    





Alumni

                        Find news on alumni of any org
                    





Your Contacts

                        Find news on your contacts
                    












                Free Daily Alerts
            


                Sign up for free daily alerts on this feed
            




Sign Up ➤

                    By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions




                Already have an account?  Click here to login.















Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤















Barry Flannelly Facebook, Twitter & MySpace on PeekYou















































































 Name
 Username
 Phone




Search by Name



Please enter a First Name



Please enter a Last Name




Location
World
USA
AlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutWashington, DCDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachussetsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming

Please enter the location





























Search Tools



Jump To:

Social Media
Public Records
Phone
Email
Web Search
Images


1 Match for Barry Flannelly









Country





Region





City





Gender
Male
Female



Age 


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99


 - 


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99















 










Public Records & Background Checks












































						 Barry Flannelly - Instant Search
					


					View Now


					Free addresses, phone numbers, and social media links
				 







Arrest Records & Driving Infractions










					 Barry Flannelly				





				Search their Arrest Records, Driving Records, Contact Information, Photos and More...	
			 







Phonebook









							We Found  Barry Flannelly						











							1)  Barry Flannelly's Phone & Current Address
						


 View All Details











						2) Social Media Profiles & More - Search Free!
					


 View All Details


















							 Barry Flannelly's Phone #, Address & More
						


 View All Details











							 Barry Flannelly's Contact Info, Social Profiles & More
						


 View All Details


















					 Barry Flannelly - Get Contact Information
				



				Phone Number











					 Barry Flannelly - Reverse Phone Search - Get Photos & Online Profiles Instantly!
				



				Phone Number








Email Addresses












						View Barry's Hidden Profiles on Facebook and 60+ Networks, barry****@gmail
					











						View Barry's Hidden Profiles on Facebook and 60+ Networks, barry****@yahoo
					











						View Barry's Hidden Profiles on Facebook and 60+ Networks, barry****@hotmail
					











						View Barry's Hidden Profiles on Facebook and 60+ Networks, barry****@aol
					











							View Barry's Hidden Profiles on Facebook and 60+ Networks, barry****@outlook
						








Contact Information & Address History










					 Barry Flannelly				





				Discover  Barry Flannelly's address history, phone, age & more.
			 







Facebook








Twitter








Pinterest








Wikipedia








Instagram








Google+








Linkedin








Foursquare








Music








Photo Albums








Myspace











Documents








Web Search








Images




































Find Out Who Called!






				There was a time when a ringing phone was a mysterious beckoning, one approached with bravery and cautious optimism. Most phones have been equipped wi…
			
Read More





















































 











   







































Scroll



 
Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















People: Incyte Corp (INCY.O)





Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				INCY.O on Nasdaq


				133.70USD
10:08am EDT





				    Change	(% chg)


		    
						    $0.98


					            (+0.74%)
					        






Prev Close

$132.72


Open

$132.60




Day's High

$134.93


Day's Low

$132.18




Volume

128,041


Avg. Vol

1,813,429




52-wk High

$153.15


52-wk Low

$75.52










	Flannelly, Barry 





	Mr. Barry P. Flannelly is Executive Vice President and General Manager , US of Incyte Corporation., He joined Incyte as Executive Vice President, Business Development and Strategic Planning in August 2014. Prior to joining Incyte, he served as Chief Executive Officer of OSS Healthcare Inc., a biotechnology start-up company, from August 2013 to July 2014. He served as Vice President, Global Product Strategy and Commercial Planning of Nektar Therapeutics, a biopharmaceutical company, from April 2011 until April 2013 and as Senior Vice President, Commercial, of Onyx Pharmaceuticals, Inc., a biopharmaceutical company, from August 2008 until January 2011. Prior thereto, Dr. Flannelly held key positions at biopharmaceutical and pharmaceutical companies such as Abraxis BioScience, Inc. and Novartis. Dr. Flannelly earned his doctorate in pharmacy from the University of Maryland, School of Pharmacy, his master’s degree in business administration from the University of Baltimore, and his B.S. degree in Pharmacy from Massachusetts College of Pharmacy.



Basic Compensation




Total Annual Compensation, 
--


Restricted Stock Awards, 
--


Long-Term Incentive Plans, 
--


All Other, 
--


Fiscal Year Total, 
--








Options Compensation




 
Quantity
Market Value


Exercisable
--
--


Unexercisable
--
--


Exercised
--
--














					Basic Compensation






Name
Fiscal Year Total




							Herve Hoppenot

11,807,100




							David Gryska

3,268,170




							Reid Huber

4,063,340




							Eric Siegel

--




							Paula Swain

1,327,560




							Barry Flannelly

--



As Of 
30 Dec 2016

» View All Officers
















Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research




















